查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1138384

全球生育补充剂市场-2022-2029

Global Fertility Supplements Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

对天然材料不断增长的需求推动了市场增长。

在预测期内，对生育补充剂的需求预计会增加。老年人口的增长和对预防性医疗保健解决方案的兴趣增加是推动全球市场增长的某些因素。随着教育系统的改进，对天然成分的偏好正在增加。对含有红三叶草、月见草油和葡萄籽提取物等成分的生育补充剂的需求明显增加。预计这些努力将对整个市场的增长产生积极影响。

此外，医生经常推荐生育补充剂来解决不育问题。预计这将对全球市场产生积极影响。

内容

第一章调查方法及范围

  • 调查方法
  • 市场范围

第 2 章主要趋势和发展

第 3 章执行摘要

  • 按成分划分的市场细分
  • 按产品划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 对天然材料的需求不断增加具有积极影响
      • 计划生育法规的变化促进了中国及其他地区的增长
    • 约束因素
      • 对副作用的担忧增加
    • 商机
  • 影响分析

第五章行业分析

  • 波特五力分析
  • 价值链分析
  • 专利分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措

第 7 章按成分分类

  • 自然
  • 合成/混合天然和合成

第 8 章按产品分类

  • 胶囊
  • 粉末
  • 药片
  • 软胶囊
  • 液体

第 9 章，最终用户

  • 男
  • 女性

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 竞争场景
  • 竞争对手战略分析
  • 市场情况/份额分析
  • 併购分析

第 12 章公司简介

  • Fairhaven Lenus
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Coast Science Lenus
  • Pharma GmbH
  • Active Bio Life Science GmbH
  • Orthomol
  • Exeltis USA, Inc.
  • PregPrep LLC
  • TTK Healthcare Ltd.
  • Bestmade Natural Products
  • Shenzhen Hemp Bio-Tech Co., Ltd
  • CURIVO HEALTHCARE LLP
  • NUTRIFACTOR LABORATORIES（PVT.）LIMITED
  • Xiamen Yuanzhidao Biotechnology Co., Ltd.

第13章 DataM

简介目录
Product Code: DMHCIT3077

Market Overview

Fertility Supplements Market size was valued at USD 1,977.30 million in 2021 and is estimated to reach at a compound annual growth rate (CAGR) of 9.60% over the forecast period 2022 to 2029.

Fertility assists in producing offspring; however, in certain cases, failure in this process leads to infertility. To overcome such issues, there has been developed by pharmaceutical companies with the introduction of medicines in the form of soft gels, capsules, powders, liquids, and others. These drugs assist in treating infertility problems in men and women. Fertility supplements, also termed fertility drugs, are medications that improve reproductive fertility. For women, a fertility supplement is used to promote follicle development of the ovary. The increasing embracing of herbal medicines due to the rising concerns involving the harmful effects linked with conventional pharma drugs is likely to create growth opportunities for product manufacturers. Several government initiatives for generating awareness about innovations in supplement research and superior technology have helped consumers make supplement choices.

Market Dynamics: Rising Demand for Natural Ingredients drives market growth.

The demand for fertility supplements is expected to rise over the forecast period. The rising geriatric population and the increasing interest in preventive healthcare solutions are certain factors encouraging the growth of the market across the globe. With the rise in the education system, there is a rise in the preference for natural ingredients. There is an apparent rise in the demand for fertility supplements that contain ingredients, such as red clover, primrose oil, or grape seed extracts. These efforts are likely to have an encouraging impact on the overall market growth.

Moreover, doctors often recommend fertility supplements to assist couples and parents cope with their fertility concerns. This is expected to have a positive impact on the global market.

However, amendments in family planning regulations in China. With the introduction of the "one-child-per-couple" policy in China, the fertility of women has been negatively impacted.

Market Segmentation: The powder segment accounted for the highest share in global fertility supplements market.

The fertility supplements market has been classified into capsules, tablets, soft gels, powders, and liquids based on the product.

The fertility supplement powder segment dominated the market in 2022. It is owing to increasing awareness regarding the nutritional benefits linked with these products. These products facilitate unique mixes of ingredients, reduce gastrointestinal irritation, and ensure oil and fat-soluble nutrient delivery.

Based on the end-users, the fertility supplements market has been classified into men and women. The men segment accounted significant market share in the fertility supplements market during the forecast period. Immune system factors, varicocele, hypogonadism, systemic disease, urogenital infection, sexual factors, and undescended testicles are some of the major factors leading to fertility problems in men. In the last 50 years, sperm concentration has fallen considerably by 52% among men in Western countries. The drop is alarming as sperm concentration below 40 million per milliliter is considered below normal and can worsen fertility. All these factors have resulted in an increasing demand for fertility supplements for men.

Geographical Penetration: North America is the dominating region during the forecast period.

North America contributed the largest revenue share to the global fertility supplements market in 2022. This dominance is due to the presence of several key market players in the region, especially in the US. Moreover, the increasing health concerns among consumers further support the market growth in the region. Additionally, the growing prevalence of obesity and the rising number of diabetic patients in the region is augmenting the demand for fertility supplements in North America. However, Asia Pacific is projected to grow at the fastest CAGR in the global fertility supplements market over the forecast period. This growth is attributed to the change in the lifestyle of customers and the increase in health consciousness among the consumers. The market in this region is observing a radical transformation regarding rapid urbanization, diet diversification, and liberal trade policies in the food sector. Furthermore, an increase in the inclination of consumers toward healthy food products and a surge in purchasing power are certain factors offering growth opportunities for fertility supplements manufacturers in the region.

Competitive Landscape:

The fertility supplements market is highly competitive, owing to the presence of big food brands. The critical fertility supplements players which are contributing to the growth of the global market include Fairhaven Health, Coast Science Lenus, Pharma GesmbH, Active Bio Life Science GmbH, Orthomol Exeltis USA, Inc. PregPrep LLC, TTK Healthcare Ltd., Best made Natural Products, Curivo Healthcare Llp, Nutrifactor Laboratories (Pvt.) Limited, Xiamen Yuanzhidao Biotechnology Co., Ltd. and Shenzhen Hemp Bio-Tech Co., Ltd., among others. The major players are adopting new launches based on new material launches and expansion strategies for global growth in the fertility supplements market. In August 2022, Youtheory, a supplement brand, expanded its new line of liquid dietary supplements. This company is acquired by Canadian firm Jamieson wellness in a deal of $210 million. In April 2022, Ovaterra launched New Prenatal Vitamins in the market for fertility treatment. The supplements, designed in collaboration with fertility author Rebecca Fett, contain the full recommended daily allowance of choline. These two supplements are named Advanced Prenatal and Advanced Prep 35-39. Advanced Prep 35-39 includes 25mg of patented FERTINATAL, a micronized DHEA and is designed specifically for women aged 35-39, the more advanced reproductive age range.

COVID-19 Impact: Positive impact on the global fertility supplements market.

COVID-19 has led to an increase in fertility supplements amidst the pandemic. The company engaged in the fertility supplements market has witnessed a nominal surge in revenue during the pandemic. This is because COVID-19 certainly impacts the fertility level of a person, owing to which an intake of supplements has increased for fertility supplements post the outbreak of COVID-19.

Table of Contents

1. Scope and Methodology

  • 1.1. Research Methodology
  • 1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary

  • 3.1. Market Snippet by Ingredients
  • 3.2. Market Snippet by Product
  • 3.3. Market Snippet by End Use
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market impacting factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Demand for Natural Ingredients to Have a Positive Impact
      • 4.1.1.2. Amendments in Family Planning Regulations to Propel Growth in China and Elsewhere
    • 4.1.2. Restraints
      • 4.1.2.1. Increasing concerns regarding the side effects
    • 4.1.3. Opportunities
  • 4.2. Impact analysis

5. Industry Analysis

  • 5.1. Porter's five forces analysis
  • 5.2. Value chain analysis
  • 5.3. Patent Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives

7. By Ingredients

  • 7.1. Introduction
    • 7.1.1. Market size analysis, and y-o-y growth analysis (%), By Ingredients Segment
    • 7.1.2. Market attractiveness index, By Ingredients Segment
  • 7.2. Natural *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 7.3. Synthetic/Blend of Natural & Synthetic

8. By Product

  • 8.1. Introduction
    • 8.1.1. Market size analysis, and y-o-y growth analysis (%), By Product Segment
    • 8.1.2. Market attractiveness index, By Product Segment
  • 8.2. Capsules *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 8.3. Powder
  • 8.4. Tablets
  • 8.5. Soft gels
  • 8.6. Liquids

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market size analysis, and y-o-y growth analysis (%), By End User Segment
    • 9.1.2. Market attractiveness index, By End User Segment
  • 9.2. Men *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 9.3. Women

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key region-specific dynamics
    • 10.2.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.2.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.2.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. South America
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.3.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.3.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.3.6.1. Brazil
      • 10.3.6.2. Argentina
      • 10.3.6.3. Rest of South America
  • 10.4. Europe
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.4.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.4.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.4.6.1. Germany
      • 10.4.6.2. U.K.
      • 10.4.6.3. France
      • 10.4.6.4. Spain
      • 10.4.6.5. Italy
      • 10.4.6.6. Rest of Europe
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.5.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.5.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.6.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.6.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive scenario
  • 11.2. Competitor strategy analysis
  • 11.3. Market positioning/share analysis
  • 11.4. Mergers and acquisitions analysis

12. Company Profiles

  • 12.1. Fairhaven Lenus*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Coast Science Lenus
  • 12.3. Pharma GmbH
  • 12.4. Active Bio Life Science GmbH
  • 12.5. Orthomol
  • 12.6. Exeltis USA, Inc.
  • 12.7. PregPrep LLC
  • 12.8. TTK Healthcare Ltd.
  • 12.9. Bestmade Natural Products
  • 12.10. Shenzhen Hemp Bio-Tech Co., Ltd
  • 12.11. CURIVO HEALTHCARE LLP
  • 12.12. NUTRIFACTOR LABORATORIES (PVT.) LIMITED
  • 12.13. Xiamen Yuanzhidao Biotechnology Co., Ltd.
  • List not Exhaustive*

13. DataM

  • 13.1. Appendix
  • 13.2. About us and services
  • 13.3. Contact us